February 18, 2016
February 18, 2016 —
As men age, their testosterone levels decrease, but prior studies of the effects of administering supplements of the hormone to older men have been inconclusive. Now, researchers at University of California, San Diego School of Medicine and 12 other medical centers in the United States have shown that testosterone treatment for men over the age of 65 improves sexual function, walking ability and mood.
January 4, 2016
January 4, 2016 —
The Physician Payments Sunshine Act, passed under the Affordable Care Act, requires all pharmaceutical and medical device companies to report payments to physicians, including consulting fees, gifts, speaking fees, meals, travel and research grants. This information is searchable to the public on a database called Open Payments, managed by the Centers for Medicare & Medical Services (CMS). A recent study by researchers at University of California, San Diego School of Medicine analyzed this database and compared payments among different specialties and identified which ones topped the list.
December 15, 2015
December 15, 2015 —
Texting a friend, using a GPS device or talking on a cell phone while driving – even hands-free – can put lives in danger. Distracted driving has emerged as a major transportation safety problem. To combat it, researchers at University of California, San Diego School of Medicine recently received funding for the ninth consecutive year from the California Office of Traffic Safety through the National Highway Traffic Safety Administration.
December 10, 2015
December 10, 2015 —
When someone experiences a major stroke, almost two million nerve cells in the brain die each minute, emphasizing the need for rapid treatment. Stroke patients who receive life-saving interventions more quickly have a higher chance of recovery. A recent data analysis showed the Comprehensive Stroke Center at UC San Diego Medical Center exceeded national average treatment times, and as a result, has received a “Get With The Guidelines-Stroke Gold Plus Quality Achievement Award” from The American Heart Association and American Stroke Association (AHA/ASA).
October 20, 2015
October 20, 2015 —
A teenage girl faced with sudden rapid heart deterioration, a man in the prime years of his life suffering from debilitating heart failure and a former NFL athlete crippled by end-stage heart failure were all successfully treated with a surgical approach pioneered by cardiac experts at University of California, San Diego School of Medicine.
September 29, 2015
September 29, 2015 —
The votes are in and more than 100 physicians from UC San Diego Health were named “Top Docs” in the annual San Diego Magazine “Physicians of Exceptional Excellence” annual survey. These physicians represent 41 diverse specialties, from family medicine, surgery and oncology to obstetrics, cardiology and emergency medicine.
September 21, 2015
September 21, 2015 —
Approximately 20 million Americans will experience some type of gastroesophageal reflux disease, or GERD, in their lives. In some cases, patients suffer resulting heart burn or acid regurgitation so severe that they require surgery to repair damage to their esophagus. A clinical trial at UC San Diego Health is using a new, FDA-approved device that reconstructs the esophagus through the mouth and requires no incisions.
September 2, 2015
September 2, 2015 —
From comprehensive stroke care when every second counts to stitching deep cuts and evaluating flu symptoms, UC San Diego Health provides the highest quality of care when patients arrive through the emergency room doors. Now, as part of a long term partnership between UC San Diego Health and El Centro Regional Medical Center (ECRMC), patients in the Imperial Valley will receive the same specialty emergency care.
August 24, 2015
August 24, 2015 —
Patty Maysent, MPH, MBA, has been appointed interim Chief Executive Officer of UC San Diego Health, bringing to the role more than 25 years of exceptional executive experience in hospital leadership and health services management.
July 21, 2015
July 21, 2015 —
Roughly 20 to 30 percent of patients with hepatitis C virus (HCV) are also infected with human immunodeficiency virus type 1 (HIV). Both blood-borne viruses share the same modes of transmission, but many HCV medications currently have significant limitations due to adverse interactions with HIV treatments. Researchers at University of California, San Diego School of Medicine report a new combination that effectively treats HCV in patients co-infected with HIV.
